Interim analysis of the randomized PATSGO trial evaluating the prolongation of adjuvant temozolomide in newly diagnosed glioblastoma patients.

2044 Background: The standard treatment of GBM is curently maximal surgical resection followed by 6 weeks of radiochemotherapy and 6 months of adjuvant temozolomide (TMZ). Nevertheless, nearly half...